March 2021
![](https://www.altasciences.com/sites/default/files/2021-03/Newsletter-Header_March-2021.jpg)
In this issue
The latest complimentary webinars, industry podcasts and articles, bioanalytical assays, and more!
![](https://www.altasciences.com/sites/default/files/2021-03/altascientist_thumbnails.jpg)
The Altascientist
Exploring microsampling applications, benefits, and considerations in preclinical, clinical, and bioanalytical research during early phase drug development. Includes two case studies!
![](https://www.altasciences.com/sites/default/files/2021-03/article-1_thumbnails.jpg)
Making Early Phase Drug Development More Efficient
Engaging with a single partner through the critical early stages can make all the difference.
![](https://www.altasciences.com/sites/default/files/2021-03/article-2_thumbnails.jpg)
Timely PK Analysis Supports Data-Driven Decisions
Exploring the benefits of including pharmacokinetic analysis between cohorts in first-in-human studies.
![](https://www.altasciences.com/sites/default/files/2021-03/industry-news_thumbnail.jpg)
Industry News
Keep up to date on the latest news from and about Altasciences.
CONTINUE READING
- Webinars
View the latest on-demand webinars and catch up on some of our favorites, including a new presentation on navigating the abuse potential evaluation of CNS-active drugs for European and American submissions. - Podcasts
HListen to discussions about the principles of the 3Rs in preclinical studies, large molecule bioanalysis, Altasciences’ unique approach to scientific project management, and research support services. - Up Close and Personal with…
Meet Dr. Gaetano Morelli, Chief Medical Officer at Altasciences. - Blog
Learn more about protocol design concepts in Phase I ethnobridging clinical trials.
LET'S STAY CONNECTED!